07:06 AM EDT, 08/07/2025 (MT Newswires) -- Eli Lilly ( LLY ) reported Q2 non-GAAP earnings Thursday of $6.31 per diluted share, up from $3.92 a year earlier.

Analysts surveyed by FactSet expected $5.60.

Revenue for the quarter ended June 30 was $15.56 billion, up from $11.30 billion a year earlier.

Analysts surveyed by FactSet expected $14.70 billion.

For full-year 2025, non-GAAP EPS is projected to be $21.75 to $23, up from the previous outlook of $20.78 to $22.28. Analysts surveyed by FactSet expect $21.94.

Revenue for the full year is now projected to be $60 billion to $62 billion, up from the previous outlook of $58 billion to $61 billion. Analysts surveyed by FactSet expect $60.23 billion.

Eli Lilly ( LLY ) shares were down 13% in recent Thursday premarket activity.

Price: 649.80, Change: -96.57, Percent Change: -12.94